Psychiatric Morbidity in Huntington's Disease: The current view

Neurology Psychiatry and Brain Research

Volumn 8, Issue 1, 2000, Pages 5-16

  Wagle, A C ^a   Wagle, S A ^a   Markova I S ^b   Berrios, G E ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF HULL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0346737555     PISSN: 09419500     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (135)

1. Hayden MR. Huntington'c Chorea. Berlin, Germany: Springer-Verlag; 1981.
2. Huntington's Disease Collaborative Research Group. (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable in Huntington's disease chromosomes. Cell 72: 971-983.
3. Martin JB, Gusella JF. (1986) Huntington's disease: pathogenesis and management. New England Journal of Medicine 315: 506-526.
4. Gusella JF, Wexler NS, Connealy PM, Naylor SL, Anderson MA, Tanzi RE, Watkins PC, Ottina K, Wallace MR, Sakaguchi AY, Young AB, Shoulson I, Bonilla E, Martin JB. (1983) A polymorphic DNA marker genetically linked to Huntington's disease. Nature 306: 234-238.
5. Huntington G. (1872) On chorea. Medical and Surgery Reporter (Philadelphia) 26: 317-321.
6. Bruyn GW. Huntington's Chorea. In Handbook of Clinical Neurology, vol.6, pp. 298-378. North-Holland: Amsterdam, 1968.
7. Berrios GE, Markov IS, Gimbert R. (1995) The role of psychiatry in genetic prediction programmes for Huntington's disease. Psychiatric Bulletin 19:203-206.
8. Berrios GE & Quemada JI (1990) Depressive illness in multiplesclerosis: clinical and theoretical aspects of the association. British Journal of Psychiatry 156: 10-16.
9. Berrios G E & Samuel B. (1987) Affective Disorder in the Neurological Patient. Journal of Nervous and Mental Disease 175: 173-176.
10. Berrios GE, Dening TR. (1990) Biological and quantitative issues in neuropsychiatry Behavioural Neurology 3: 247-259.
11. Berrios GE, Wagle AC, Markov IS, Wagle SA, Ho LW, Rubinsztein DC, Whitteker J, Kershaw A, ffrench-Constant C, Rosser A, Hodges JR. (2000) Psychiatric symptoms and CAG repeats in neurologically asymptomatic Huntington's disease gene carriers: a comparisonwith gene negative at risk subjects. Archives of General Psychiatry (submitted).
12. Zappacosta B, Monza D, Meoni C, Austoni L, Soliveri P, Gallera C, Alberti R, Mantero M, Penati G, caraceni T, Girotti F. (1996) Psychiatric symptoms do not correllate with cognitive decline, motorsymptoms, or CAG repeat length in Huntington's disease. Archives of Neurology 53: 493-497.
13. Weigell-Weber M, Schmid W, Spiegal R. (1996) Psychiatric symptoms and CAG expansion in Huntington's disease. American Journal of Medical Genetics. 67: 53-57.
14. Campodonico J.R., Codori A.M. & Brandt. J (1996) Neuropsychological stability over two disease mutation. Journal of Neurology, Neurosurgery & Psychiatry 61:621-4
15. Andrew SE, Goldberg P, Kremer B, Telenius H, Theilmann J, Adam S, Starr E, Saquiteri F, Lin B, Kalchman MA, Graham RK, Hayden MR. (1993) The relationship between trinucleotide (CAG) repeat length & clinical features of Huntington's disease. Nature Genetics 4:398-403
16. MacMillan JC, Snell RG, Taylor A et al. (1993) Molecular analysis and clinical correlations of the Huntington's disease mutation. Lancet 342: 954-958
17. Illarioshkin SN, Igarashi S, Onodera O, Markova ED, Nikolskaya NN, Tanaka H, Chabrashwili TZ, Insarova NG, Endo K, Ivanova-Smolenskaya IA, Tsuji S. (1994) Trinucleotide repeat length and rate of progression of Huntington's disease. Annals of Neurology 36:630-5.
18. Brandt J, Bylsma FW, Gross BA, Stine OC, Ranen N, Ross CA. (1996) Trinucleotide repeat length and clinical progression in Huntington's disease. Neurology 46: 527-31
19. Penney J.B., Vonsattel J-P, MacDonald M.E.; Gusella J.F., Myers, R.H. (1997) CAG repeats number governs the development rate of pathology in Huntington's disease. Annals of Neurology 41: 689-692.
20. Jason GW, Suchowersky O, Pajurkova EM, Graham L, Klimek ML, garber AT, Poirer-Heine D. (1997) Cognitive manifestations of Huntington's disease inrelation to genetic structure and clinical onset. Archives of neurology 54: 1081-1088.
21. Snell RG, MacMillan JC, Cheadle JP, et al. (1993) Relationship between trinucleotide repeat expansion and phenotype variation in Huntington's disease. Nature Genetics 4: 393-397.
22. Lawrence AD, Hodges JR, Rosser AE, Kershaw A, ffrench-Constant C, Rubinsztein DC, Robbins TW, Sahakian BJ. (1998)* Evidence of specific cognitive deficits in preclinical Huntington's disease. Brain 121: 1329-41.
23. Read AP. (1993) Huntington's disease: testing the test. Nature Genetics 4:329-330.
24. Marková I.S. & Berrios G.E. (1995). Insight in Clinical Psychiatry. Journal nervous and mental Disease 183: 743-751.
25. Harper PS (ed). Huntington's Disease London: Saunders; 1991.
26. Pflanz S, Besson JAO, Ebmeier KP, Simpson S. (1991) The clinical manifestation of mental disorder in Huntington's disease: a retrospective case record study of disease progression. Acta Psychiatrica Scandinavica 83: 53-60.
27. Webb M & Trzepacz PT. (1987) Huntington's disease: Correlations of mental status with chorea. Biological Psychiatry 22: 751-761.
28. Boll TJ, Heron R, Retian RM. (1974) Neuropsychological and emotional correlates of Huntington's chorea. The Journal of Nervous and Mental Disease158: 61-69.
29. Caine ED & Shoulson I. (1983) Psychiatric syndrome in Huntington's disease. American Journal of Psychiatry 140: 728-733.
30. Wallace DC & Hall AC. (1972) Evidence of genetic heterogeneity in Huntington's chorea. Journal of Neurology, Neurosurgery and Psychiatry 35: 789-800.
31. Dewhurst K, Oliver J, Trick KLK, McKnight AL. (1969) Neuropsychiatric aspects of Huntington's disease. Confin Neurology 31: 258-268.
32. Lyon RL. (1962) Huntington's chorea in Moray Firth area. British Medical Journal 1:1301-1306.
33. Folstein SE, Abbott MH, Chase GA, Jensen BA, Folstein MF. (1983) The association of affective disorde rwith Huntington's disease in a case series and in families. Psychological Medicine 13: 537-542.
34. Mattson B. (1974)Huntington's chorea in Sweden: Social and clinical data. Acta Psychiatrica Scandinavica-supplement 255: 221-235.
35. Saugstad L & Odegard O. (1986) Huntington's chorea in Norway. Psychological Medicine 16: 39-48.
36. Baxter LR, Mazziotta JC, Pahl JJ, Grafton ST, St George-Hislop P, Haines JL, Gusella JF, Szuba MP, Selin CE, Guze BH, Phelps ME. (1992) Psychiatric, genetic and positron emission tomographic evaluation of persons at risk for Huntington's disease. Archives of General Psychiatry 49: 148-154.
37. Shiwach R & Norbury G. (1994) A controlled psychiatric study of individuals at risk for Huntington's disease. British Journal of Psychiatry 165: 500-505.
38. Hamilton AS. (1908) A report of 27 cases of chronic progressive chorea. American Journal of Insanity 64: 403-475.
39. Oliver JE. (1970) Huntington's chorea in Northamptonshire. British Journal of Psychiatry 116: 241-253.
40. Bolt JMW. (1970) Huntington's chorea in West of Scotland. British Journal of Psychiatry 116: 259-270.
41. Brothers CRD & Meadows AW. (1955) An investigation of Huntington's chorea in Victoria. Journal of Mental Science 101: 548-563.
42. Dewhurst K, Oliver JE, McKnight AL. (1970) Sociopsychiatric consequences of Huntington's disease. British Journal of Psychiatry 116: 255-258.
43. Davenport CB. Huntington's chorea in relation to heredity and eugenics. (1916) American Journal of Insanity 73: 195-222.
44. Bickford JAR & Ellison RM. (1953) The high incidence of Huntington's chorea in the Duchy of Cornwall. Journal of Mental Science. 99: 291-294.
45. McHugh PR & Folstein MF. Psychiatric syndromes of Huntington's chorea: A clinical and phenomenological study. In Benson DF. Blummer D (eds): Psychiatric Aspects of Neurological Diseases. New York, Grune & Stratton Inc., 1975, pp 267-286.
46. Folstein SE, Chase GA, Wahl WE, McDonnell AM, Folstein MF. (1987) Huntington's disease in Maryland: Clinical aspects and racial variation. American Journal of Human Genetics 41: 168-179.
47. Shiwach R. (1994) Psychopathology in Huntington's disease. Acta Psychiatrica Scandinavica. 90: 241-246.
48. Mindham RHS, Steele C, Folstein MF, Lucas J. (1985) A comparison of frequency of major affective disorder in Huntington's disease and Alzheimer's disease. Journal of Neurology, Neurosurgery and Psychiatry 48: 1172-1174.
49. Folstein SE, Franz ML, Jensen BA, Chase GA, Folstein MF. (1983) Conduct disorder and affective disorder among the offspring of patients with Huntington's disease. Psychological Medicine 13: 45-52.
50. Marsden CD. (1982) Basal ganglia disease. Lancet 2: 1141-1146.
51. Weinberger DR, Berman KF, Iadarola M, Driesen N, Zee RF. (1988) Prefrontal cortical blood flow and cognitive function in Huntington's disease. Journal of Neurology, Neurosurgery and Psychiatry 51: 94-104.
52. Saint-Cyr JA, Taylor AE, Nicholson K. (1995) Behaviour and basal ganglia. Advances in Neurology 65: 1-28.
53. Peyser CE & Folstein SE. (1990) Huntington's disease as a model for mood disorders. Clues from neuropathology and neurochemistry. Molecular and Chemical Neuropathology 12: 99-119.
54. Reed TE, Chandler JH. (1958) Huntington's chorea in Michigan. I. Demography and genetics. American Journal of Human Genetics 10: 201-225.
55. Schoenfeld M, Mayers RH, Cupples LA, Berkman B, Sax D, Clark E. (1984) Increased rate of suicide among patients with Huntington's disease. Journal of Neurology, Neurosurgery and Psychiatry 47: 1283-1287.
56. Lipe H, Schultz A, Bird TD. (1993) Risk factors for suicide in Huntington's disease: a retrospective case controlled study. American Journal of Medical Genetics 48: 231-233.
57. Jensen P, Sorensen SA, Fenger F, Bowling TG. (1993) A study of psychiatric morbidity in patients with Huntington's disease, their relatives and controls. British Journal of Psychiatry 163: 790-797.
58. Cooper JE, Kendell RE, Gurland BJ, Sharp L, Copeland JRM, Simon R. Psychiatric diagnoses in New York and London. Maudsley Monograph No. 20. Oxford University Press: London, 1972.
59. Folstein SE, Folstein MF, McHugh PR. (1979) Psychiatric syndromes in Huntington's disease. Advances in Neurology 23: 281-289.
60. Folstein SE & Folstein MF. (1983) Psychiatric features of Huntington's disease: recent approaches and findings. Psychiatric Developments 2: 193-206.
61. Folstein SE & McHugh PR. The neuropsychiatry of some specific brain disorders. In Handbook of Psychiatry, vol 2, Mental Disorders and Somatic Illness, Lader MH (ed), 1983; pp 107-118. Cambridge University Press: Cambridge.
62. Tsuang D, DiGiacomo L, Lipe H, Bird TD. (1998) Familial aggregation of schizophrenia like symptoms in Huntington's disease. American Journal of Medical Genetics 81: 323-327.
63. Watt DC & Seller A. (1993) A clinicogenetic study of psychiatric disorder in Huntington's chorea. Psychological medicine-Monograph supplement 23: 3-46.
64. Spokes EGS. (1980) Neurochemical alterations in Huntington's chorea: a study of postmortem brain tissue. Brain 103: 179-210.
65. Cummings JL & Cunningham K. 1992) Obsessive-compulsive disorder in Huntington's disease. Biological Psychiatry 31: 263-270.
66. Tonkongy J, Barreira P. (1989) Obsessive-compulsive disorder and caudate frontal lesion. Neuropsychiatry, Neuropsychology and Behavioural Neurology 2: 203-209.
67. De Marchi N, Morris M, Meneeella R, La Pia S, Nestadt G. (1998) Association of obsessive-compulsive disorder and pathological gambling with Huntington's disease in an Italian pedigree: possible association with Huntington's disease mutation. Acta Psychiatrica Scandinavica 97: 62-65.
68. Martin A, Pigott TA, Lalonde FM, Dalton I, Dubbert B, Murphy DL. (1993) Lack of evidence for Huntington's disease-like cognitive dysfunction in obsessive-compulsive disorder. Biological Psychiatry 33: 345-353.
69. Shepherd M & Sartorius N. (1974) Personality disorder and the International Classification of Diseases. Psychological Medicine 4: 141-146.
70. Rosenbaum D. (1941) Psychosis with Huntington's chorea. Psychiatric Quarterly 15: 93-99.
71. Chandler JH, Reed TE, DeJong RN. (1960) Huntington's chorea in Michigan. III. Clinical observations. Neurology 10: 148-153.
72. Brothers CRD. (1964) The history and incidence of Huntington's chorea in Tasmania. Journal of Neurological Science 1: 405-420.
73. Dewhurst K. (1970) Personality disorder in Huntington's disease. Psychiatrica Clinica 3: 221-229.
74. Kehrer F. Erblichkeit und Nervenleiden. I. Ursachen und Erblichkeitskreis von Chorea, Myoklonie und Athetose. Monographien aus dem gesamtgebiete der Neurologie und Psychiatrie. 1928; Vol. 50. Springer: Berlin.
75. Panse F. Die Erbchorea. Eine klinisch-genetische Studie. 1942; Thieme: Leipzig.
76. Huber G. Psychiatrie (3rd ed). Schattauer: Stuttgart, 1981. 6th ed. 1999
77. Ranen NG, Peyser CE, Folstein SE. (1994) ECT as a treatment of depression in Huntington's disease. Journal of Neuropsychiatry and Clinical Neurosciences 6: 154-159.
78. Lewis CF, DeQuardo JR, Tandon R. (1996) ECT in genetically confirmed Huntington's disease. Journal of Neuropsychiatry and Clinical Neurosciences 8: 209-210.
79. Aylward EH, Anderson NB, Bylsma FW, Wagster MV, Barta PE, Sherr M, Feeney J, Davis A, Rosenblatt A, Pearlson GD, Ross CA. (1998) Frontal lobe volume in patients with Huntington's disease. Neurology 50: 252-258.
80. Hanes KR, Andrews DG, Pantelis C. (1995) Cognitive flexibility and complex integration in Parkinson's disease, Huntington's disease and schizophrenia. Journal of International Neuropsychological Society 1: 545-553.
81. Lange KW, Sahakian BJ, Quinn NP, Marsden CD, Robbins TW. (1995) Comparison of executive and visuospatial memory function in Huntington's disease and dementia of Alzheimer's type matched for degree of dementia. Journal of Neurology, Neurosurgery and Psychiatry 58: 598-606.
82. Hodges JR, Salmon DP, Butters N. (1990) Differential impairment of semantic and episodic memory in Alzheimer's and Huntington's disease: a controlled prospective study. Journal of Neurology, Neurosurgery and Psychiatry 53: 1089-1095.
83. Hans MB & Gilmore TH. (1968) Social aspects of Huntington's chorea. British Journal of Psychiatry 114: 93-98.
84. Hughes EM. (1925) Social significance of Huntington's chorea. American Journal of Psychiatry 81: 537-573.
85. Spillane J & Phillips R. Huntington's chorea in South Wales. (1937) Quarterly Journal of Medicine 6: 403-423.
86. King M. (1985) Alcohol abuse in Huntington's disease. Psychological Medicine 15: 815-819.
87. Shiwach RS, Patel V (1993) Aggressive behaviour in Huntington's disease: a cross-sectional study in a nursing home population. Behavioural Neurology 6: 43-47.
88. Burns A, Folstein SE, Brandt J, Folstein MF. (1990) Clinical assessment of irritability, aggression and apathy in Huntington's and Alzheimer's disease. The Journal of Nervous and Mental Disease 178: 20-26.
89. Snaith RP, Constantopoulos AA, Jardine MY, McGuffin P. (1978) A clinical scale for the self-assessment of Irritability. British Journal of Psychiatry 132: 164-171.
90. Tamir A, Whittier J, Koorenyi C. (1969) Huntington's chorea: a sex difference in psychopathological symptoms. Diseases of the Nervous System 30: 103.
91. Huber SJ & Paulson GW. (1985)The concept of subcortical dementia. American Journal of Psychiatry 142: 1312-1317.
92. Wilson SAK. (1912) Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of liver. Brain 107: 313-325.
93. Caine ED, Hunt RD, Weingartner H, Ebert MH. (1978) Huntington's dementia. Archives of General Psychiatry 35: 377-384.
94. Georgiou N, Bradshaw JL, Phillips JG, Chiu E. (1996) The effect of Huntington's disease and Gilles de la Tourette's syndrome on the ability to hold and shift attention. Neuropsychologia 34: 843-851.
95. Claus JJ & Mohr E. (1996) Attentional deficits in Alzheimer's parkinson's and Huntington's disease. Acta Neurologica Scandinavica 93: 346-351.
96. Gomez-Tortosa E, del Barrio A, Barroso T, Garcia Ruiz PJ. (1996) Visual processing disorder in patients with Huntington's disease and asymptomatic carriers. Journal of Neurology 243: 286-292.
97. Filotio JV, Delis DC, Roman MJ, Demadura T, Ford E, Butters N, Salmon DP, Paulsen J, Shults CW, Swenson M. (1995) Visual attention and perception in patients with Huntington's disease: comparisons with other subcortical and cortical dementias. Journal of Clinicaland Experimental Neuropsychology 17: 654-667.
98. Butters N, Sax D, Montgomery K, Tarlow S. (1978) Comparison of the neuropsychological deficits associated with early and advanced Huntington's disease. Archives of Neurology 35: 585-589.
99. Gomez-Tortosa E, del Barrio A, Garcia Ruiz PJ, Pernaute RS, Benitez J, Barroso A, Jimenez FJ, garcia YJ. (1998) Severity of cognitive impairment in juvenile and late onset Huntington's disease. Archives of Neurology 55: 835-843.
100. Lundervold AJ, Reinvang I, Lundervold A. (1994) Characteristic patterns of verbal memory functions in patients with Huntington's disease. Scandinavian Journal of Psychology 35: 38-47.
101. Randolph C. (1991) Implicit, explicit and semantic memory functions in Alzheimer's disease and Huntington's disease. Journal of Clinical and Experimental Neuropsychology 13: 479-494.
102. Knopman D & Nisssen MJ. (1991) Procedural learning is impaired in Huntington's disease: evidence from the serial reaction time task. Neuropsychologia 29: 245-254.
103. Granholm E & Butters N. (1988) Associative encoding and retrieval in Alzheimer's and Huntington's disease. Brain and Cognition 7: 335-347.
104. Smith S, Butters N, White R, Lyon L, Granholm E. (1988) Priming semantic relations in patients with Huntington's disease. Brain and Language 33: 27-40.
105. Butters N, Wolfe J, Granholm E, Martone M. (1986) An assessment of verbal recall, recognition and fluency abilities in patients with Huntington's disease.Cortex 22: 11-32.
106. Pillon B, Deweer B, Agid Y, Dubois B. (1993) Explicit memory in Alzheimer's, Huntington's and Parkinson's disease. Archives of Neurology 50: 374-379.
107. Rouleau I, Salmon DP, Butters N, Kennedy C, McGuire K. (1992) Quantitative and qualitative analyses of clock drawings in Alzheimer's and Huntington's disease. Brain and Cognition 18: 70-87.
108. Mohr E, Brouwers P, Claus JJ, Mann UM, Fedio P, chase TN. (1991) Visuospatial cognition in Huntington's disease. Movement Disorders 6: 127-132.
109. Brouwers P, Cox C, martin A, Chase T, Fedio P. (1984) Differential perceptual-spatial impairment in Huntington's and Alzheimer's dementias. Archives of neurology 41: 1073-1076.
110. Paulsen JS, Butters N, Sadek JR, Johnson SA, Salmon DP, Swerdlow NR, Swenson MR. (1995) Distinct cognitive profiles of cortical and subcortical dementiain advanced illness. Neurology 45: 951-956.
111. Bamford KA, Caine ED, Kido DK, Cox C, Shoulson I. (1995) A prospective ealuation of cognitive decline in early Huntington's disease: functional and radiological correlates. Neurology 45: 1867-1873.
112. Hahn-Barma V, Deweer B, Durr A, Dode C, Feingold J, Pillon B, Agid Y, Brice A, Dubois B. (1998) Are cognitive changes the first symptoms of Huntington's disease? A study of gene carriers. Journal of Neurology, Neurosurgery and Psychiatry 64: 172-177.
113. Gomez-Tortosa E, del Barrio A, Pernaute SR, Benitez J, Barroso A, garcia YJ. (1997) Cognitive assessment of asymptomatic Huntington's disease carriers. Neurologia 12: 226-231.
114. Dimond R, White RF, Myers RH, mastromauro C, Koroshetz WJ, Butters N, Rothstein DM, Moss MB, Vasterling J. (1992) Evidence of presymptomatic cognitive decline in Huntington's disease. Journal of Clinical and Experimental Neuropsychology 14: 961-975.
115. Schulterbrandt JG, Raskin A, Reatig N. (1974) Further replication of factors of psychopathology in the interview, ward behaviour and self-reported ratings of hospitalized depressed patients. Psycholgical Rep 34: 23-32.
116. Fedoroff JP, Peyser C, Franz ML, Folstein SE. (1994) Sexual disorders in Huntington's disease. Journal of Neuropsychiatry and Clinical Neurosciences 6: 147-153.
117. Folstein SE. Huntington's disease. A disorder of families. Baltimore: John Hopkins University Press; 1989.
118. Gorman DG & Cummings JL. (1992) Hypersexuality following septal injury. Archives of Neurology 49: 308-310.
119. Hansotia P, Wall R, Berendes J. (1985) Sleep disturbance and severity of Huntington's disease. Neurology 35: 1672-1674.
120. Silvestri R, Raffaele M, De Domenico P, Tisano A, Mento G, Casella C, Tripoli MC, Serra S, Di Perri R. (1995) Sleep features in Tourette's syndrome, neuroacanthocytosis and Huntington's chorea. Neurophysiological Clinics 25: 66-77.
121. Taylor N. & Bramble D. (1997) Sleep Disturbance and Huntington's disease. British Journal Of Psychiatry 171:393.
122. Pendlebury SC, Moses DK, Eadie MJ. (1989) Hyponatremia during oxcarbazepine therapy. Human Toxicology 8: 337.
123. Steinhoff BJ, Stroll KD, Stodieck SR, Palulus W. (1992) Hyponatremic coma under oxcarbazepine therapy. Epilepsy Research 11: 67.
124. Betts TA, Crowe A, Alford C. (1982) Psychotropic effects of sodium valproate. British Journal of Clinical Practice (Suppl) 18: 145.
125. Brown JD, Larson EB. (1993) Drug induced cognitive impairment: defining the problem and finding solutions. Drugs and Aging 3: 349.
126. Van Putten T, May PRA, Marder SR. (1984) Akathisia with haloperidol and thiothixane. Archives of General Psychiatry 41: 1036.
127. Jain AK, Kewala S, Gershon S. (1988) Antipsychotic drugs in schizophrenia: current issues. International Journal of Clinical Psychopharmacology 3: 1-30.
128. Bye C, Clubley M, Peck AW. (1978) Drowsiness, impaired performance and tricyclic antidepressant drugs. British Journal of Clinical Pharmacology 6: 155.
129. Hemmingsen R, Rafaelsen OJ. (1980) Hypnagogic and hypnopompic hallucinations during amitriptyline treatment. Acta Psychiatric Scandinavica 62: 364.
130. Feighner JP, Boyer WF, Tyler DL, Nebrosky RJ. (1990) Adverse consequences of fluoxetine-MAOI combination therapy. Journal of Clinical Psychiatry 51: 222.
131. Lader M. (1995) Handbook of Clinical Neurology (Vol. 65) Amsterdam: Elsevier.
132. Foy A, O'Connell D, Henry D. (1995) Benzodiazepine use as a cause of cognitive impairment in elderly hospital inpatients. Journal of Gerontology 50A:M99.
133. Strahan A, Rosenthal J, Kaswan M, Winston A. (1985) Three case reports of acute paroxysmal excitement associated with alprazolam treatment. American Journal of Psychiatry 142: 859-861.
134. Goetz CG, Cohen MM. (1994) Neurotoxic agents. Clinical Neurology 20: 1.
135. Head L. & Berrios G.E. (1996) "Impaired Judgement". A useful symptom of dementia? International Journal of Geriatric Psychiatry 11: 779-785.